Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 9, Number 12—December 2003

Dispatch

Visceral Leishmaniasis Treatment, Italy

Luigi Gradoni*Comments to Author , Marina Gramiccia*, and Aldo Scalone*
Author affiliations: *Istituto Superiore di Sanità, Rome, Italy

Main Article

Figure 2

Annual proportion of immunocompetent patients with visceral leishmaniasis treated with meglumine antimoniate (MA) or amphotericin B (AmB) in the period 1995–2001.

Figure 2. Annual proportion of immunocompetent patients with visceral leishmaniasis treated with meglumine antimoniate (MA) or amphotericin B (AmB) in the period 1995–2001.

Main Article

TOP